Linda Öster
Impact in
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
-
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
Papers in
-
- Biochemical and Molecular Research 4
- Protein Kinase Regulation and GTPase Signaling 3
- Enzyme function and inhibition 3
- PI3K/AKT/mTOR signaling in cancer 3
- Genetics 5
- Chronic Lymphocytic Leukemia Research 3
- Co-authors
- Yafeng Xue (5 shared papers)János Hajdu (3 shared papers)Inger Andersson (4 shared papers)Anke C. Terwisscha van Scheltinga (2 shared papers)K. Valegård (2 shared papers)Helena Käck (4 shared papers)Alain Dubus (2 shared papers)Graziella Ranghino (1 shared paper)
- Journals
- Journal of Biological Chemistry (3 papers)Journal of Medicinal Chemistry (2 papers)Journal of Molecular Biology (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)PLoS ONE (1 paper)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Linda Öster
24 papers receiving 509 citations
Peers
Comparison fields: 5 of 94
- Internal Medicine 38
- Genetics 62
- Biochemistry 40
- Pharmacology 36
- Pharmacology 67
Countries citing papers authored by Linda Öster
This map shows the geographic impact of Linda Öster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Öster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Öster more than expected).
Fields of papers citing papers by Linda Öster
This network shows the impact of papers produced by Linda Öster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Öster. The network helps show where Linda Öster may publish in the future.
Co-authors
The 25 scholars most cited alongside Linda Öster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 75 | |
| 2 | 2015 | 64 | |
| 3 | 2008 | 61 | |
| 4 | 2015 | 48 | |
| 5 | 2019 | 39 | |
| 6 | 2015 | 28 | |
| 7 | 2018 | 24 | |
| 8 | 2004 | 20 | |
| 9 | 2020 | 19 | |
| 10 | 2015 | 19 | |
| 11 | 2006 | 19 | |
| 12 | 2013 | 17 | |
| 13 | 2001 | 15 | |
| 14 | 2021 | 12 | |
| 15 | 2016 | 12 | |
| 16 | 2014 | 12 | |
| 17 | 2016 | 11 | |
| 18 | 2022 | 9 | |
| 19 | 2024 | 4 | |
| 20 | 2021 | 3 |
About Linda Öster
Linda Öster is a scholar working on Molecular Biology, Genetics, Organic Chemistry, Materials Chemistry and Oncology, having authored 24 papers that have together received 517 indexed citations. Recurring topics across this work include Biochemical and Molecular Research (4 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Enzyme function and inhibition (3 papers), Enzyme Structure and Function (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Liquid Crystal Research Advancements (2 papers) and Metal-Catalyzed Oxygenation Mechanisms (2 papers). The work is most often cited by research in Internal Medicine (38 citations), Genetics (62 citations), Biochemistry (40 citations), Pharmacology (36 citations) and Pharmacology (67 citations). Linda Öster has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Yafeng Xue, János Hajdu, Inger Andersson, Anke C. Terwisscha van Scheltinga, K. Valegård, Helena Käck, Alain Dubus, Graziella Ranghino, Vicky M. Avery and Johanna Deinum. Their work appears in journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry, Journal of Molecular Biology, Bioorganic & Medicinal Chemistry Letters and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.